BMY vs. GILD
Compare and contrast key facts about Bristol-Myers Squibb Company (BMY) and Gilead Sciences, Inc. (GILD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BMY or GILD.
Performance
BMY vs. GILD - Performance Comparison
Returns By Period
In the year-to-date period, BMY achieves a 15.11% return, which is significantly higher than GILD's 12.63% return. Over the past 10 years, BMY has outperformed GILD with an annualized return of 2.74%, while GILD has yielded a comparatively lower 1.70% annualized return.
BMY
15.11%
5.64%
31.08%
16.17%
3.51%
2.74%
GILD
12.63%
1.90%
33.37%
23.56%
10.79%
1.70%
Fundamentals
| BMY | GILD | |
|---|---|---|
| Market Cap | $121.33B | $120.90B |
| EPS | -$3.53 | $0.08 |
| PEG Ratio | 2.20 | 0.57 |
| Total Revenue (TTM) | $47.44B | $28.30B |
| Gross Profit (TTM) | $33.40B | $5.63B |
| EBITDA (TTM) | $18.32B | $9.32B |
Key characteristics
| BMY | GILD | |
|---|---|---|
| Sharpe Ratio | 0.51 | 0.92 |
| Sortino Ratio | 1.01 | 1.39 |
| Omega Ratio | 1.12 | 1.19 |
| Calmar Ratio | 0.30 | 0.76 |
| Martin Ratio | 1.26 | 1.57 |
| Ulcer Index | 11.52% | 14.42% |
| Daily Std Dev | 28.61% | 24.79% |
| Max Drawdown | -70.62% | -70.82% |
| Current Drawdown | -24.61% | -9.70% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between BMY and GILD is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
BMY vs. GILD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BMY vs. GILD - Dividend Comparison
BMY's dividend yield for the trailing twelve months is around 4.27%, more than GILD's 3.46% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.27% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
GILD Gilead Sciences, Inc. | 3.46% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% | 0.00% | 0.00% |
Drawdowns
BMY vs. GILD - Drawdown Comparison
The maximum BMY drawdown since its inception was -70.62%, roughly equal to the maximum GILD drawdown of -70.82%. Use the drawdown chart below to compare losses from any high point for BMY and GILD. For additional features, visit the drawdowns tool.
Volatility
BMY vs. GILD - Volatility Comparison
Bristol-Myers Squibb Company (BMY) has a higher volatility of 13.64% compared to Gilead Sciences, Inc. (GILD) at 9.60%. This indicates that BMY's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BMY vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Bristol-Myers Squibb Company and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities